We have submitted our new Industry Partner Consortium (IPC) Annual report, "Enhancing Excellence: Strategic Recommendations for Optimizing Extramural Research Across the VA," to the House and Senate Veterans' Affairs Committees (HVAC, SVAC), the Appropriations Committees, and the Military Construction, Veterans Affairs, and Related Agencies Subcommittees (MilCon-VA).

This report, developed in collaboration with our IPC, outlines four key recommendations for advancing clinical trials within the VA. By streamlining processes and expanding partnerships, we aim to ensure that veterans across the country have access to cutting-edge treatments and life-saving interventions.

We are grateful to our partners, including BCG, bioAffinity Technologies, Bristol Myers Squibb, Cognition Therapeutics, Genentech, Johnson & Johnson, MITRE, and Siemens Healthineers, for their contributions.